A Phase 2 interventional study of the FibroNova device in fibromyalgia

Recruiting Not Applicable NCT06271746

Study Description

Evaluating the Safety and Effectiveness of the FibroNova Device for Treating Fibromyalgia Pain and Related Symptoms

Study Details

Registry ID:: NCT06271746
Conditions:: Fibromyalgia
Phase:: Not Applicable
Target Enrollment:: 170 participants
Start Date:: March 4, 2024
Age Range:: 18–70 years
Healthy Volunteers:: No

Study Locations (4 sites)

Tel Aviv Sourasky Medical Center
Tel AvivIsrael, Israel
Gershon Pain Specialists
Virginia Beach, VirginiaUnited States, United States
Clinical Research Professionals
Chesterfield, MissouriUnited States, United States
ClinVest Headlands Research
Springfield, MissouriUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →